Such models include the Eμ-MYC model of B cell leukemia/lymphoma, the TH-MYCN model of neuroblastoma, the Lo-MYC and Hi-MYC models of prostate cancer, and the involucrin-c-mycER skin cancer model [24,25,26,27]. The gene discussed is MYC; the disease is prostate cancer.